Dr Cecile King
Senior Research Fellow; Group leader, Immunology and Inflammation Research Program, Garvan Institute of Medical Research
Email: c.king 'at' garvan.org.au
Research Group: Mucosal Autoimmunity
Cecile’s group is looking at the role of a cytokine (or protein) called interleukin 21 (IL 21) and its role in a variety of autoimmune diseases, including type 1 diabetes.
Education
PhD Institute for Child Health Research, University of Western Australia
BSc University of Western Australia
Publilcations
King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004; 117:265-277.
King C, Mueller R, Malo Cleary M, Krishner M, Ahmed R, King E, Sarvetnick N. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T cell responses. Nature Medicine 2001; 7:206-214.
King C, Davies J, Mueller R, Lee M-S, Krahl T, Yeung B, O'Connor E, Sarvetnick N. TGF-β1 alters APC preference, polarizing islet antigen responses to Th2. Immunity 1998; 8:601-613.
King C, Brennan S, Thompson PJ, Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. Journal of Immunology 1998; 3645-3651
King C, Sarvetnick N. Organ-specific autoimmunity (Review). Current Opinion in Immunology 1997; 9(6):863-71
